CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
August 2020—Randox Laboratories has unveiled cytokine testing for COVID-19 risk stratification and treatment monitoring. The tests look for the presence of cytokines and are performed using Randox’s Biochip technology, which can detect up to 12 cytokines and growth factors from a single patient sample. The testing menu includes 26 cytokines across four biochip panels.
The test is suitable for use with serum and plasma samples and is compatible with the Randox Evidence and Evidence Investigator analyzers, which are capable of processing 2,960 and 2,376 tests per hour, respectively.
Pages: 1 2